secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001828185-24-000060
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus shareholders approve all proposals at 2024 AGM, re-elect directors
----------------------------------------------------------------------------

- Three directors re-elected: William Enright, Alex Hammacher, Robin Wright with >98% of votes cast.
- PricewaterhouseCoopers LLP reappointed as UK statutory auditors and ratified as independent auditor for FY 2024.
- Advisory vote on directors' compensation report for FY 2023 passed with ~99.8% approval.
- No dividend for FY 2023 as recommended by directors; annual accounts received.
- Broker non-votes were ~3 million shares (about 13.6% of quorum) on certain items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000182818524000060/0001828185-24-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000182818524000060/brns-20240510.htm
  HTML page:      https://secwatch.observer/filing/0001828185-24-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer